Fillers and Neuromodulators for Cosmetic Lip Enhancement
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines a new approach called "Kiss and Smile HIT" to enhance lips. The goal is to assess how well this method improves lip volume, framing, and expression using treatments like Dysport (a neuromodulator that acts as a muscle relaxer) and Restylane fillers. Individuals with thin lips, poorly defined lip shape, or difficulty smiling confidently might be suitable candidates. Participants should be in good health and willing to have their photos used for marketing and education. As a Phase 4 trial, this research involves treatments that are already FDA-approved and proven effective, aiming to understand how they benefit more patients.
Do I need to stop my current medications for this trial?
The trial information does not specify if you need to stop taking your current medications. However, if you are taking immunosuppressant medication, you cannot participate in the trial.
What is the safety track record for Dysport neuromodulator and Restylane line of dermal fillers?
Research shows that Dysport, a type of muscle relaxer, is generally safe for cosmetic use. Skilled professionals have reported no serious issues when administering it. The most common complaints are minor, such as bruising, redness, or pain at the injection site.
Studies on Restylane, a filler often used for lip enhancement, show similar results. Most side effects are mild and temporary, including swelling, pain, or small bumps. The FDA has approved Restylane for various cosmetic uses, indicating a strong safety record when used correctly.
Past studies have shown that most patients tolerate both treatments well, making them generally safe options for lip enhancement.12345Why are researchers enthusiastic about this study treatment?
Unlike the standard lip enhancement options that typically focus on either volume or shaping, the combination of Dysport neuromodulator and Restylane dermal fillers offers a comprehensive approach. This treatment targets not just lip volume, but also framing and expression, making it versatile for different cosmetic needs. Researchers are excited because it uses hyaluronic acid to provide natural-looking results with the added potential for quicker touch-ups, offering more personalized and lasting enhancements compared to existing treatments.
What evidence suggests that the Kiss and Smile HIT approach is effective for cosmetic lip enhancement?
In this trial, participants will receive both Dysport and Restylane treatments. Research has shown that Dysport works well for cosmetic treatments, particularly in enhancing facial appearance. Users report that the effects last about 3 to 4 months, with approximately 95% expressing satisfaction with the results.
For Restylane fillers, studies have highlighted excellent results in enhancing lips. About 96% of participants felt their lips looked natural after treatment, and there was a 99% success rate in restoring lip volume. Most noticed improvements lasting up to 18 months. Both Dysport and Restylane have strong research support for their effectiveness in cosmetic procedures.26789Who Is on the Research Team?
Andreas Nikolis, MD
Principal Investigator
Erevna Innovations Inc.
Are You a Good Fit for This Trial?
This trial is for individuals seeking cosmetic enhancements specifically for their lips and smile. Ideal candidates are those looking to address issues like volume loss, poorly defined lip contours, or expression-related concerns that affect confidence in their smile.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive active treatment with hyaluronic acid at Baseline, with an optional touch-up at week two
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dysport neuromodulator
- Restylane line of dermal fillers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Erevna Innovations Inc.
Lead Sponsor